1. Order No 1/2010 of President of AHTAPol dated 4 January 2010 on guidelines on health technology assessment. English— http://www.aotm.gov.pl/assets/files/wytyczne_hta/2009/Guidelines_HTA_eng_MS_29062009.pdf (02-02-2014)
2. Regulation of the Minister of Health of 2 April 2012 on the minimum requirements to be satisfied by analyses accounted for in the applications for reimbursement and setting the official sales price and for increasing the official sales price of a drug, a special purpose dietary supplement, a medical device, which do not have a reimbursed counterpart in a given indication. http://www.aotm.gov.pl/assets/files/wytyczne_hta/2012/Regulation_MoH_minimum_requirements_03042012_eng.pdf (02-02-2014)
3. Act on the Reimbursement of Drugs, Food Products for Special Dietary Purposes and Medical Devices with Public Funds 12 May 2011, Journal of Laws 2011 No 122, Poz. 696
4. Kolasa, K., Schubert, S., Manca, A., Hermanowski, T.: A review of health technology assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in Poland. Health Policy 102, 145–151 (2011)
5. Kolasa, K., Wasiak, R.: Health technology assessment in Poland and Scotland: comparison of process and decisions. Int. J. Tech. Assess. Health Care 27(1), 70–76 (2011)